Product Reports Resources Pricing Login Book a demo

Precision for Medicine

Biotech & Life Sciences · Chevy Chase, United States · Founded 2012

Discovery, development, clinical trial work, and implementation of biomarkers essential for targeting patients more precisely and effectively MoreLess

Precision For Medicine is a global clinical research organization (CRO) that specializes in integrating advanced technologies to maximize insights into patient biology. The company serves life sciences clients, including pharmaceutical and biotechnology companies, by supporting clinical trials at every stage from first-in-human to regulatory approval. Precision For Medicine operates in the precision medicine market, focusing on oncology, cell and gene therapy, and rare and orphan diseases. The business model revolves around offering comprehensive clinical trial services, specialty lab services, and data sciences to enhance the speed, cost-efficiency, and success rate of bringing life-changing therapies to patients. Revenue is generated through contracts with life sciences companies for conducting clinical trials, providing biostatistical support, and offering specialized laboratory services.

Keywords: clinical trials, precision medicine, oncology, cell therapy, gene therapy, rare diseases, biostatistics, specialty labs, data sciences, regulatory approval.

Company overview

Precision for Medicine company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2012
Headquarters
Chevy Chase, United States
Employees
1,976
Open positions
364
Dealroom signal
50.1
Investment activity
4 companies · latest May 2024
Capital deployed
Preferred round
ACQUISITION
sub industryBioTechnologybusiness modelSaaSindustryHealthsectorData AnalyticssectorBiotechnologysectorMedical & HealthcaresectorCore AIsectorPrecision MedicinesectorDiseasesectorArts & CulturesectorClinical TrialssectorTech for Biotech and PharmasectorBiotech and PharmasectorHard Tech

Valuation & funding

Precision for Medicine funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
GROWTH EQUITY VCOther financing Dec 2015 $75M $525M TPG Growth
GROWTH EQUITY VCOther financing Apr 2013 $150M Ethan Leder · J.H. Whitney & Co · Mark Clein · Oak Investment
Showing 2 recorded eventsUnlock the complete deal history →

Growth signals

Precision for Medicine website traffic

Latest recorded traffic for Precision for Medicine is 29K monthly website visits, down 32.6% over the last three months. Precision for Medicine's team grew 4.9% over the past year.

Latest monthly visits29K 3-month web change-32.6% 1-year team growth+4.9%
Monthly website visits116 observations · Apr 2016–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Precision for Medicine compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Precision for Medicine's talent

Book a demo to see the people
Team profiled 30 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

5 investors on Precision for Medicine's cap table

Sourced from Dealroom's funding and investor records.

Series B+ 5 investors entered at this stage
J.H. Whitney & Co
Oak Investment
Ethan Leder
Mark Clein
TPG Growth

Global footprint

Where Precision for Medicine has talent and traffic

Workforce by country
30 countries with
team presence
🇺🇸 United States44.8%
🇮🇳 India15.6%
🇬🇧 United Kingdom9.3%
🇪🇸 Spain5.2%
🇷🇸 Serbia4%
Top 5 of 30 shown

In the news

Latest news about Precision for Medicine

Recent press, funding announcements, and product moves mentioning Precision for Medicine — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Precision for Medicine

An AI-synthesized read of the highest-engagement posts about Precision for Medicine on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Precision for Medicine’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.